Literature DB >> 23362823

Applicability of the MATRICS Consensus Cognitive Battery in Singapore.

Attilio Rapisarda1, Thomas F Lim, Matthew Lim, Simon L Collinson, Michael S Kraus, Richard S E Keefe.   

Abstract

The MATRICS Consensus Cognitive Battery (MCCB) was developed to provide a reliable, valid, and standard battery for clinical trials on cognitive enhancers in schizophrenia. In this study we tested the applicability of the MCCB to Singapore's English speakers. Healthy ethnic Chinese, Malay, and Indian English speakers (N = 171) of both genders were recruited within three age groups and three levels of education to match as closely as possible the US norming sample, and were administered the MCCB. Descriptive data, T scores, age, gender, education, and ethnicity effects on performance were explored and compared with the US norming study. Age, education, and ethnicity affected the battery's composite scores, with young and highly educated participants generally outperforming the old, less-educated ones. Male participants outperformed their female counterparts in two out of seven cognitive domains. Although generally lower when compared to the US norming sample, Singaporean scores reflected the same relationship with age, education, and gender, with the exception of a substantially worse performance in the social cognition domain. Differences among the ethnic groups in Singapore-and the poorer performance measured in these groups with respect to the US sample-call for the necessity of an extended norming study in Singapore.

Entities:  

Mesh:

Year:  2013        PMID: 23362823     DOI: 10.1080/13854046.2012.762120

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  6 in total

1.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

2.  Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.

Authors:  Christine E Marx; Jimmy Lee; Mythily Subramaniam; Attilio Rapisarda; Dianne C T Bautista; Edwin Chan; Jason D Kilts; Robert W Buchanan; Eu Pui Wai; Swapna Verma; Kang Sim; Jayaraman Hariram; Rajesh Jacob; Richard S E Keefe; Siow Ann Chong
Journal:  Psychopharmacology (Berl)       Date:  2014-07-17       Impact factor: 4.530

3.  The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China.

Authors:  Chuan Shi; Lan Kang; Shuqiao Yao; Yibin Ma; Tao Li; Ying Liang; Zhang Cheng; Yifeng Xu; Jianguo Shi; Xiufeng Xu; Congpei Zhang; Donald R Franklin; Robert K Heaton; Hua Jin; Xin Yu
Journal:  Schizophr Res       Date:  2015-10-04       Impact factor: 4.939

4.  Dysfunction of Nrf2-ARE Signaling Pathway: Potential Pathogenesis in the Development of Neurocognitive Impairment in Patients with Moderate to Severe Obstructive Sleep Apnea-Hypopnea Syndrome.

Authors:  Li Zhou; Ruoyun Ouyang; Hong Luo; Yating Peng; Ping Chen; Siying Ren; Guiqian Liu
Journal:  Oxid Med Cell Longev       Date:  2018-08-12       Impact factor: 6.543

5.  Neuropsychological profile in adult schizophrenia measured with the CMINDS.

Authors:  Theo G M van Erp; Adrian Preda; Jessica A Turner; Shawn Callahan; Vince D Calhoun; Juan R Bustillo; Kelvin O Lim; Bryon Mueller; Gregory G Brown; Jatin G Vaidya; Sarah McEwen; Aysenil Belger; James Voyvodic; Daniel H Mathalon; Dana Nguyen; Judith M Ford; Steven G Potkin
Journal:  Psychiatry Res       Date:  2015-10-26       Impact factor: 3.222

6.  The relationship between IQ and performance on the MATRICS consensus cognitive battery.

Authors:  Christine Mohn; Kjetil Sundet; Bjørn Rishovd Rund
Journal:  Schizophr Res Cogn       Date:  2014-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.